Lantheus

Alzheimers brain
MedTech

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify

Lantheus, which recently agreed to a takeover by fellow radiopharma Curium, garnered FDA clearance for its Alzheimer’s PET imaging agent Tauklarify.
Joseph Keenan Aug 17, 2026 7:51am
MA

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm
FDA

Production problems hamper Lantheus FDA approval of dx kit

Jun 29, 2026 8:31am
GE Healthcare Building

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am
parachute sunset paragliding chutes

Ikena and Inmagene choose combined CEO—Chutes & Ladders

Jul 25, 2025 8:30am
medical data concept with hospital in the background

ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto

Sep 16, 2024 8:55am